INS and type 1 diabetes mellitus: For example, a randomized trial of adults with T1D was conducted to investigate the safety of, and glucose control by, faster aspart in the insulin-only configuration of the iLet® bionic pancreas (iLet; Beta Bionics, Inc., Concord, MA), fully automated insulin delivery system.13 The results suggest that glucose control is even further improved when the time to maximal serum drug concentration (tmax) setting is adapted to the pharmacological profile of faster aspart.